{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:26:05Z","timestamp":1793395565617,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jtct.2023.01.014","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T23:28:17Z","timestamp":1674170897000},"page":"270.e1-270.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Factors Affecting Day-to-Day Variations in Tacrolimus Concentration among Children and Young Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"29","author":[{"given":"Yuta","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1423-5527","authenticated-orcid":false,"given":"Yuya","family":"Maejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2193-1184","authenticated-orcid":false,"given":"Koichi","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Morokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Okura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yozo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.01.014_bib0001","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3324\/haematol.2016.156356","article-title":"Improved survival after acute graft-versus-host disease diagnosis in the modern era","volume":"102","author":"Khoury","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.01.014_bib0002","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.01.014_bib0003","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/asheducation-2018.1.228","article-title":"Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation","volume":"2018","author":"Hamilton","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtct.2023.01.014_bib0004","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jtct.2021.03.012","article-title":"Guidelines for the prevention and management of graft-versus-host disease after cord blood transplantation","volume":"27","author":"Ponce","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.01.014_bib0005","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2023.01.014_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.605726","article-title":"GVHD prophylaxis 2020","volume":"12","author":"Gooptu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2023.01.014_bib0007","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1083-8791(98)50005-5","article-title":"Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation","volume":"4","author":"Wingard","year":"1998","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.014_bib0008","first-page":"2303","article-title":"Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation","volume":"92","author":"Ratanatharathorn","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.01.014_bib0009","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/bmt.2009.327","article-title":"Relationship betweentacrolimus blood concentrations and clinical outcome during the first 4 weeks after SCT in children","volume":"45","author":"Watanabe","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.014_bib0010","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bbmt.2014.11.679","article-title":"Efficacy of tacrolimus\/mycophenolate mofetil as acute graft-versus-host disease prophylaxis and the impact of subtherapeutic tacrolimus levels in children after matched sibling donor allogeneic hematopoietic cell transplantation","volume":"21","author":"Offer","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.014_bib0011","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/sj.bmt.1703224","article-title":"Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients","volume":"28","author":"Jacobson","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.014_bib0012","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation","volume":"43","author":"Staatz","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtct.2023.01.014_bib0013","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00002018-200225100-00003","article-title":"Drug interactions with tacrolimus","volume":"25","author":"van Gelder","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.jtct.2023.01.014_bib0014","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00228-009-0702-z","article-title":"Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study","volume":"65","author":"Liu","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jtct.2023.01.014_bib0015","first-page":"1315","article-title":"Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability","volume":"23","author":"Lampen","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jtct.2023.01.014_bib0016","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1034\/j.1600-6143.2002.21018.x","article-title":"Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients","volume":"2","author":"Maes","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jtct.2023.01.014_bib0017","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/bmt.2015.222","article-title":"A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation","volume":"51","author":"Kanda","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.014_bib0018","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12185-016-2135-7","article-title":"Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation","volume":"105","author":"Suetsugu","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.01.014_bib0019","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jtct.2023.01.014_bib0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/clpt.2009.210","article-title":"Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients","volume":"86","author":"Zhao W","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtct.2023.01.014_bib0021","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00228-013-1584-7","article-title":"Importance of hematocrit for a tacrolimus target concentration strategy","volume":"70","author":"St\u00f8rset","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jtct.2023.01.014_bib0022","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0009-9236(95)90153-1","article-title":"Pharmacokinetics of tacrolimus in liver transplant patients","volume":"57","author":"Jusko","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtct.2023.01.014_bib0023","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s11096-020-01038-9","article-title":"Effects of red blood cell concentrate transfusion on blood tacrolimus concentration","volume":"42","author":"Uchida","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jtct.2023.01.014_bib0024","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.clinbiochem.2014.03.023","article-title":"Multi-center analytical evaluation of a novel automated tacrolimus immunoassay","volume":"47","author":"Shipkova","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jtct.2023.01.014_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2009.09.009","article-title":"Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS\/MS) and Abbott IMx methods","volume":"410","author":"De","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jtct.2023.01.014_bib0026","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.014_bib0027","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1056-8719(02)00158-2","article-title":"Validation of methods to study the distribution and protein binding of tacrolimus in human blood","volume":"46","author":"Zahir","year":"2001","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.jtct.2023.01.014_bib0028","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/bmt.2010.64","article-title":"Engraftment syndrome, but not acute GVHD, younger age, CYP3A5 or MDR1 polymorphisms, increases tacrolimus clearance in pediatric hematopoietic SCT","volume":"46","author":"Yanagisawa","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.014_bib0029","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/17425255.2016.1170808","article-title":"Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations","volume":"12","author":"Tang","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jtct.2023.01.014_bib0030","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00003088-200241110-00003","article-title":"Mechanisms of clinically relevant drug interactions associated with tacrolimus","volume":"41","author":"Christians","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtct.2023.01.014_bib0031","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/17425255.2020.1803277","article-title":"Predictors of tacrolimus pharmacokinetic variability: current evidence and future perspectives","volume":"16","author":"Degraeve","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jtct.2023.01.014_bib0032","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/1389200219666180129151948","article-title":"Pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation","volume":"19","author":"Yu","year":"2018","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.jtct.2023.01.014_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230195","article-title":"Pharmacogenetic-whole blood and intracellular pharmacokinetic-pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients","volume":"15","author":"Tron","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2023.01.014_bib0034","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1432-2277.2011.01365.x","article-title":"Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study","volume":"25","author":"Capron","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.jtct.2023.01.014_bib0035","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.clinbiochem.2013.02.011","article-title":"Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients","volume":"46","author":"Lemaitre","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jtct.2023.01.014_bib0036","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.clinbiochem.2014.12.018","article-title":"Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells","volume":"48","author":"Lemaitre","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jtct.2023.01.014_bib0037","doi-asserted-by":"crossref","first-page":"e4416","DOI":"10.1002\/bmc.4416","article-title":"Highly sensitive and rapid determination of tacrolimus in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry","volume":"33","author":"Bahmany","year":"2019","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.jtct.2023.01.014_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.750433","article-title":"Monitoring tacrolimus concentrations in whole blood and peripheral blood mononuclear cells: inter- and intra-patient variability in a cohort of pediatric patients","volume":"12","author":"De Nicol\u00f2","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtct.2023.01.014_bib0039","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.transproceed.2015.12.096","article-title":"Correlation of hematocrit and tacrolimus level in liver transplant recipients","volume":"48","author":"Limsrichamrern","year":"2016","journal-title":"Transplant Proc"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723000428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723000428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T21:20:22Z","timestamp":1721683222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723000428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2666636723000428"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.01.014","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors Affecting Day-to-Day Variations in Tacrolimus Concentration among Children and Young Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}